| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 107,181 | 101,657 | 76,108 | | Cost of Revenue | 61,621 | 55,482 | 35,340 | | | Gross Profit | 45,560 | 46,175 | 40,768 | | | Operating Expenses | | Research Development | 14,597 | 15,563 | 14,558 | | Selling General and Administrative | 43,693 | 44,797 | 37,830 | | Non Recurring | 1,641 | 1,458 |
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (14,371) | (15,643) | (11,620) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 702 | 2,860 | 2,709 | | Earnings Before Interest And Taxes | (13,669) | (12,783) | (8,911) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (13,669) | (12,783) | (8,911) | | Income Tax Expense | 161 | (330) | (62) | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (13,830) | (12,453) | (8,849) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| 128 | | Other Items |
-
|
-
|
-
| | | | Net Income | (13,830) | (12,453) | (8,721) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($13,830) | ($12,453) | ($8,721) |
|
0.26% Nasdaq 
0.07 (2.37%) 
Income Statement
